MD-CARE Act 2001 Congressional Briefing

The MD-CARE Act has transformed life for Americans impacted by many forms of Muscular Dystrophy. Because of the MD-CARE Act (first passed in 2001): -- The lifespan of the average patient with Duchenne has increased by 10 years over the same period of time; -- More than $200 million have been committed to Duchenne research and innovation activities, spurring a non-governmental investment of several billion dollars in potential therapies. -- Nearly 20 potential therapies are in clinical testing with several others in earlier stages of development. You can help us continue this progress. Contract your Members of Congress today: http://www.ParentProjectMD.org/TakeAc...